Lactoferrin peptide increases the survival of Candida albicans - Inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor

Infection and Immunity

Volumn 69, Issue 6, 2001, Pages 3883-3890

  Tanida, T ^a   Rao, F ^a   Hamada, T ^a   Ueta, E ^a   Osaki, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LACTOFERRIN; PEPTIDE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FUNGUS GROWTH; GROWTH INHIBITION; INFECTION CONTROL; INJECTION; INOCULATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SURVIVAL; TREATMENT OUTCOME;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LACTOFERRIN; MACROPHAGES; MICE; MICE, INBRED CBA; NEUTROPHILS; PEPTIDES; UP-REGULATION;

EID: 0035001420     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.6.3883-3890.2001     Document Type: Article

References (64)

1. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
2. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens
3. Production and function of cytokines in natural and acquired immunity to Candida albicans infection
4. The effect of aggregation state of amphotericin-B on its interactions with cholesterol- or ergosterol-containing phosphatidylcholine monolayers
5. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin
6. Salivary histatins in patients with recurrent oral candidiasis
7. Oral infections and fever in immunocompromised patients with haematologic malignancies
8. Trend in antifungal use and epidermiology of nosocomial yeast infections in a university hospital
9. Effects of cytokines on nitric oxide pathways in human vasculature
10. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: Role in activation of human neutrophil function
11. Up-regulation of nitric oxide production by interferon-gamma in cultured peritoneal macrophages from patients with cirrhosis
12. The effect of cytokines on human neutrophil Fc receptor-mediated phagocytosis
13. Reactive oxygen species and antioxidants in inflammatory diseases
14. Cellular immunity in recurrent vulvovaginal candidiasis
15. Evolution of drug resistance in experimental populations of Candida albicans
16. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans
17. Immunological aspects of fungal pathogenesis
18. Inhibition of macrophage phagocytosis of Escherichia coil by mannnose and mannan
19. The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils
20. Candida albicans stimulates cytokine-production and leukocyte adhesion molecule expression by endothelial cells
21. Response and specificity of antibodies for Candida albicans
22. Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1
23. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: Investigations using the selective inhibitors, 1400W and celecoxib
24. Effect of granulocyte-macrophage colony-stimulating factor treatment on phenotype, cytokine release and cytotoxicity of circulating blood monocytes and monocyte-derived macrophages
25. Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans
26. Antimicrobial defensin peptides of the human ocular surface
27. Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans
28. Human granulocyte-macrophage colony-stimulating factor: An effective direct activator of human polymorphonuclear neutrophilic granulocytes
29. Granulysin: A novel antimicrobial peptide of cytotoxic T lymphocytes and natural killer cells
30. Mechanisms of the in vitro fungicidal effects of human neutrophils against Pencillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF)
31. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans
32. Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers
33. Immunology of fungal infections in animals
34. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations
35. 2 system
36. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients
37. Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor
38. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation
39. Candida albicans: A review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation
40. Inhibitory effect of prostaglandin E1 on human neutrophil function
41. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole
42. Role of cytokines, tyrosine kinase and protein kinase C in production of superoxide and induction of scavenging enzymes in human leukocytes
43. The role of complement and antibody in opsonization and intracellular killing of Candida albicans
44. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
45. The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes
46. Molecular diagnosis and epidemiology of fungal infections
47. Mechanisms controlling nitric oxide synthesis in osteoblasts
48. Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes
49. Oral mycosis in HIV infection
50. Antifungal activity of transferrin
51. Fungicidal effect of human lactoferrin against Candida albicans
52. Humoral and cellular immunity to Candida albicans in patients with bronchial asthma
53. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells
54. Granulocyte/macrophage colony-stimulating factor primes human neutrophils for increased diacylglycerol generation in response to chemoattractant
55. Regulation of Candida albicans growth and adhesion by saliva
56. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils
57. Increase of Candida cell virulence by anticancer drugs and irradiation
58. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy
59. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages
60. Factors influencing the expression in vitro of Candida albicans stress mannoproteins reactive with salivary secretory IgA
61. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori
62. Cooperative anti-Candida effect of lactoferrin or its peptides in combination with azole antifungal agents
63. In vitro susceptibility of Candida species to lactoferrin
64. A population-based study of salivary lysozyme concentrations and candidal counts